You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Dambkowski Carl · SEC Form 4 · Filed Jun 12, 2026
Sale
Calculated transaction value
$1.57M
Dambkowski Carl Director
ORKA
Oruka Therapeutics
ORKA
Transaction date
Jun 11, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed 1 day later
ORKA daily price context
Close on/before transaction
$68.47
Jun 11, 2026
First close after public filing
$68.86
Jun 15, 2026
30-day return after filing
+22.8%
Through Jul 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 22,417 shares @ $70.13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000054
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$2.45M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Jun 12, 2026 | $882.18K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Jun 11, 2026 | $1.57M |